DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
MO-IePD-TRACK 5-4 | Analysis of Time Dependency of NTCP Modeling and Dose-Volume Correlations of Patient Reported Xerostomia After HPV Associated Oropharyngeal Cancer P Mavroidis1*, A Tzikas2, E Lavdas2, R Amdur3, W Mendenhall3, N Sheets1, R Green1, L Marks1, S Das1, B Chera1, (1) University of North Carolina, Chapel Hill, NC, (2) University Of West Attica, Department Of Biomedical Sciences, Athens, Greece, (3) University of Florida Hospitals, Gainesville, FL |
MO-IePD-TRACK 5-7 | Principal Component Analysis of Dose Clustering Patterns for Parotid Toxicity Modeling in Head and Neck Radiation Therapy M Chao1*, I El Naqa2, Y Lo1, J Penagaricano2, (1) Mount Sinai Medical Center, New York, NY, (2) Moffitt Cancer Center, Tampa, FL |
MO-IePD-TRACK 6-2 | Using in Vivo EPID Measurements to Model Acute Gastrointestinal Toxicity C Bojechko*, D Simpson, T Nelson, V Moiseenko, University of California San Diego, La Jolla, CA |
PO-GePV-T-65 | NTCP Modeling of Patient Reported Dysphagia Using the EAT10 Scoring System 12 Months After Radiotherapy for Oropharyngeal Cancer B Chera1, A Tzikas2*, E Lavdas2, R Amdur3, W Mendenhall3, N Sheets1, R Green1, L Marks1, S Das1, P Mavroidis1, (1) UNC at Chapel Hill, Morrisville, NC, (2) University Of West Attica, Department Of Biomedical Sciences, Athens, Greece, (3) University of Florida Hospitals, Gainesville, FL |
PO-GePV-T-66 | Investigating the Time and Organ Dependency of NTCP Modeling of Patient Reported Sticky Saliva After HPV Associated Oropharyngeal Cancer B Chera1, A Tzikas2*, E Lavdas2, R Amdur3, W Mendenhall3, N Sheets1, R Green1, L Marks1, S Das1, P Mavroidis1, (1) University of North Carolina, Chapel Hill, NC, (2) University Of West Attica, Department Of Biomedical Sciences, Athens, Greece,(3) University of Florida Hospitals, Gainesville, FL |
PO-GePV-T-67 | NTCP Modeling and Dose-Volume Correlations of Significant Blood Count Drops 3 Months After Prostate Radiation Therapy P Papanikolaou1*, G Swanson2, S Stathakis3, P Mavroidis4, (1) Long School of Medicine, UT Health San Antonio, San Antonio, TX,(2) Baylor Scott & White Health, Temple, TX,(3) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (4) University of North Carolina, Chapel Hill, NC |
PO-GePV-T-251 | Conformal Radiotherapy with Sequential Boost Versus Intensity-Modulated Radiation Therapy with a Simultaneously Integrated Boost G Komisopoulos1*, M Tolia2, A Siountas1, S Stathakis3, N Papanikolaou3, P Mavroidis4, (1) Laboratory Of Medical Physics, School Of Medicine, Aristotle University Of Thessaloniki, Greece, (2) Department Of Radiation Therapy, University Of Crete, Herakleion, Greece,(3) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (4) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (6) University of North Carolina, Chapel Hill, NC |
PO-GePV-T-265 | Investigating the Level of Dose Trade-Offs Between Left Lung and Heart in Lung Cancer Cases to Identify Optimal Sparing K Pant1*, G Komisopoulos2, J Dooley1, K Wang1, A Weiner1, S Das1, P Mavroidis1, (1) Department of Radiation Oncology, UNC at Chapel Hill, NC, (2) Laboratory Of Medical Physics, School Of Medicine, Aristotle University Of Thessaloniki, Greece |
TU-A-TRACK 6-1 | Compact Neural Network to Predict Radiation-Induced Lymphocyte Depletion Y Kim1*, I Chamseddine2, A Saraf3, Y Cho4, F Keane5, W Sung6, H Yoon7, H Paganetti8, J Kim9, S Cho10, C Grassberger11, (1) KAIST, Daejeon, ,KR, (2) Harvard Medical School/Massachusetts General Hospital, Quincy, MA, (3) Massachusetts General Hospital, ,,(4) Yonsei University College of Medicine, Seoul, ,KR, (5) Massachusetts General Hospital, ,,(6) The Catholic University of Korea, Seoul, ,KR, (7) Yonsei University College of Medicine, Seoul, ,KR, (8) Mass General Hospital and Harvard Medical School, Boston, MA, (9) Yonsei University College of Medicine, Seoul, ,KR, (10) KAIST, Daejon, ,KR, (11) Massachusetts General Hospital, Cambridge, MA |
TU-E-TRACK 5-7 | Modeling Radiation-Induced Oxygen Depletion and Its Effects On Normal Tissue Complications in FLASH-RT S Cui1*, G Pratx2, Stanford University, Palo Alto, California |
TU-EF-TRACK 4-1 | An Imaging Based Biological Framework for Personalizing Radiation Therapy of Lung Cancer Using Interpretable Bayesian Networks and NTCP-Based Treatment Planning A Ajdari1*, T Bortfeld2, (1) Harvard Medical School & Massachusetts General Hospital, Boston, MA, (2) Massachusetts General Hospital, Boston, MA |
WE-A-TRACK 6-2 | Dose-Averaged LET in Proton Therapy for Patients with MRI Abnormalities and Its Role in Normal Tissue Complication Probability A Bertolet1*, R Abolfath2, D Carlson3, R Lustig3, C Hill-Kayser3, M Alonso-Basanta3, A Carabe-Fernandez4, (1) Massachusetts General Hospital and Harvard Medical School, Boston, MA, (2) New Jersey Urology, West Orange, NJ, (3) University of Pennsylvania, Philadelphia, PA, (4) Hampton University Proton Therapy Institute, Hampton, VA |
WE-IePD-TRACK 3-1 | A Framework of Utilizing Biological Models for Iso-Toxic Adaptive Replanning in MR-Guided Radiotherapy P Prior*, E Quashie, A Tai, X Li, Medical College of Wisconsin, Milwaukee, WI |